Description: Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
Home Page: revivapharma.com
RVPH Technical Analysis
19925 Stevens Creek Boulevard
Cupertino,
CA
95014
United States
Phone:
408 501 8881
Officers
| Name | Title |
|---|---|
| Dr. Laxminarayan Bhat Ph.D. | Founder, CEO, Pres & Director |
| Mr. Narayan Prabhu | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.5947 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2018-10-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 5 |